Rate
AI Summary: The bill aims to expand health insurance coverage for biomarker testing, which helps in diagnosing and treating diseases like cancer. It requires insurance plans to cover these tests without cost-sharing requirements for patients. This legislation seeks to improve access to precision medicine and personalized treatments by ensuring that individuals can undergo biomarker testing without financial barriers.
Latest Action: First reading, referred to Health Care & Wellness.
Contribute Your Insights: Add a Unique Perspective to Political Bills. Your Contribution will be Featured Below the Primary Bill, Ordered by Date Added.
Actions (13):
2023-01-19 : First reading, referred to Health Care & Wellness.
2023-01-31 : Public hearing in the House Committee on Health Care & Wellness at 1:30 PM.
2023-02-08 : Executive action taken in the House Committee on Health Care & Wellness at 1:30 PM.
2023-02-08 : HCW - Majority; 1st substitute bill be substituted, do pass.
2023-02-08 : Minority; do not pass.
2023-02-10 : Referred to Appropriations.
2024-01-08 : By resolution, reintroduced and retained in present status.
2024-01-18 : Committee relieved of further consideration.
2024-01-18 : Referred to Health Care & Wellness.
2024-01-26 : Public hearing in the House Committee on Health Care & Wellness at 8:00 AM.
2024-01-30 : Executive action taken in the House Committee on Health Care & Wellness at 1:30 PM.
2024-01-30 : HCW - Majority; 2nd substitute bill be substituted, do pass.
2024-01-31 : Referred to Appropriations.
Democrat Republican